The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> BIOLOGY >> NEWS
Scientists honored with 'Excellence in Clinical Research Award'

St. Louis, Mo. - 2007 Mary Tyler Moore, the Juvenile Diabetes Research Foundation's International Chairman, and her husband S. Robert Levine, M.D., will present the fifth annual Excellence In Clinical Research Award to a group of pioneering researchers for their work in regenerating beta cells -- which are destroyed in type 1 diabetes -- as a way to delay the onset of type 1 diabetes. The award will be presented at JDRF's annual conference in St. Louis.

The award recipients are Stephen J. Brand, M.D., Ph.D., who co-founded Waratah Pharmaceuticals to further the development of beta cell regeneration; Tony Cruz, Ph.D., Chief Executive Officer and a founder of Toronto-based Transition Therapeutics, which merged with Waratah Pharmaceuticals; and Alex Rabinovitch, M.D., a Professor of Medicine, co-director of the Muttart Diabetes Research & Training Centre at the University of Alberta in Edmonton, and a member of the Scientific Advisory Board at Transition Therapeutics, Inc.

This year's recipients are being acknowledged for developing and testing beta cell regeneration therapy initially in preclinical research and now in the clinic. In early preclinical studies, these researchers discovered a combination of hormones that proved to be effective at regenerating the insulin producing beta cells that are lost when people develop type 1 diabetes. These researchers are investigating ways to stimulate the existing beta cells left in diabetes patients to regenerate by applying combination therapies. If combined with therapies that block the autoimmune attack, a treatment that spurs beta cell regeneration could potentially lead to a cure for type 1 diabetes.

"Robert and I are pleased to recognize this group of dedicated and accomplished scientists for their groundbreaking work and the impact they have made on advancing our cure goal of beta cell regeneration," said Mary Tyler Moore, who has been living with type 1 diabetes for nearly 40 years.
'"/>

Contact: Brenda Cheung
bcheung@jdrf.org
212-479-7626
Juvenile Diabetes Research Foundation International
31-May-2007


Page: 1 2 3

Related biology news :

1. Scientists show that mitochondrial DNA variants are linked to risk factors for type 2 diabetes
2. Scientists prove that disputed Korean stem cell line comes from an unfertilized egg and not cloning
3. Scientists move closer to bio-engineered bladders
4. Scientists find stem cell switch
5. Scientists discover new way to study nanostructures
6. Scientists a step closer to understanding how anaesthetics work in the brain
7. Scientists to make news at Computational Biology Conference
8. Accident-prone? Scientists link brain function to knee injuries
9. Scientists take next step in understanding potential target for ovarian cancer treatment
10. Scientists find brown fat master switch
11. Scientists identify 2 distinct Parkinsons networks

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Scientists honored with Excellence Clinical Research Award

(Date:11/20/2009)... a respiratory disease commonly known as chronic b...e of death worldwide. 600 million people live wit...real treatment or cure, Grace Parraga of Robarts R...ario in London, Canada, is using various imaging t... , Parraga is a scientist in the Imaging Resear...
(Date:11/20/2009)...report that a class of heart medications called be... on the heart, depending on their molecular activi...irculation Research , found that beta-blockers tha... heart muscle offer the most benefit to cardiac pa...ptors can actually undermine the structure and fun...
(Date:11/19/2009)... of the last ice age, North America,s vast assembl...res as mammoths, mastodons, camels, horses, ground... slide to extinction. , And when their populatio...ge animals equaled or surpassed Africa,s wildlife-...el ecosystem emerged as broadleaved trees once kep...
Breaking Biology News(10 mins):Gaining a better picture of lung disease 2Carvedilol shown to have unique characteristics among beta blockers 2After mastodons and mammoths, a transformed landscape 2After mastodons and mammoths, a transformed landscape 3When H1N1 Hits Communication From Schools to Parents is Critical 57618 1When H1N1 Hits Communication From Schools to Parents is Critical 57618 2When H1N1 Hits Communication From Schools to Parents is Critical 57618 3More People Say Medical Conditions Make it Difficult To Find a Job or Remain Employed 57615 1More People Say Medical Conditions Make it Difficult To Find a Job or Remain Employed 57615 24 Stair Lifts Announces Grand Opening of Online Store 57610 14 Stair Lifts Announces Grand Opening of Online Store 57610 2
(Date:11/20/2009)...TOLEDO recently announced that a free webinar, &ld...At-Line Particle Characterization”, will be ...he application of in situ particle characterizatio...mize a series of roller compaction runs while vary...on forces. , (PRWEB) Nove...
(Date:11/19/2009)... Dr. Mate Hidvegi, inventor of Ave...ess release issued on November 17 by Biropharma Kf...alse and self-serving statements about its U.S. co...stated from his office in Budapest, Hungary: ,...es not apply to AveULTRA, www.aveultra.com , is...
(Date:11/19/2009)..., November 19 MONITORING FORCE Gmb... 2009 Flibanserin in the,indication treatment-rele...sease for orphan drug status designation with the ... dyskinesia is a complication of the mainstay,trea... to some of those,affected, since it may be disabl...
(Date:11/19/2009)..., November 19 AFFiRiS AG will focu...andidate at an unexpectedly early,stage of develop...er into,Phase II clinical trial early in 2010. Thi...completion of two Phase I trials with the candidat...ion on the first interim,analysis of the secondary...
Breaking Biology Technology:Roller Compaction Process Optimization Using At-Line Particle Characterization 2American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3
Other News:
...cientists have discovered that a remote rainforest...oration among the New York-based Wildlife Conserva... Congo, is home to a population of innovative, too...rs. According to a study in the November issue of...
...he Yerkes National Primate Research Center of Emor...this year's Society for Neuroscience meeting in Sa...chers will present findings from their studies, wh...opment to the use of infrared eye-tracking technol...
...nerally is used to measure the amount of vitamin B... deficiency of the vitamin, which has been linked ...aint Louis University research. The findings were ...Neurological Association.... ..."B12 defici...
...vartis Pharma AG announced today that Emselex (dar... granted Marketing Authorization by the European C...(OAB) in all 25 European member states as well as ...will provide many people in Europe who experience ...
Chimpanzee 'workshop' discovered in Congo 2Yerkes researchers to present array of new data at Society for Neuroscience Meeting 2Yerkes researchers to present array of new data at Society for Neuroscience Meeting 3Yerkes researchers to present array of new data at Society for Neuroscience Meeting 4Yerkes researchers to present array of new data at Society for Neuroscience Meeting 5Warning from new SLU research: Usual test for vitamin deficiency can mislead doctors 2Warning from new SLU research: Usual test for vitamin deficiency can mislead doctors 3Novartis receives European marketing authorization for Emselex(R) 2
...m studies presented at annual ASCO meeting. . New... presented data from clinical studies on the safet...iral p53) in three Phase I clinical studies for th...a (BAC), ovarian cancer and recurrent glioblastoma...
. Data Gathered from a Larger Patient Population with Ten-Year Follow-Up Consistent with Previously Reported Data. New Findings Suggest Improved Survival Even After Patient Relapse . Data Presented at
... led by a UC San Francisco scientist are reporting...ogen may protect against cognitive decline in wome...ublished in the May 23 issue of Neurology, is the ...affect her response to estrogen. . . Women who car...
...from the University of North Carolina at Chapel Hi...quickly turn a simple salt solution into a powerfu... drinking water. They report their findings today...ety for Microbiology.."Disinfection of personal wa...
Introgen Therapeutics reports advances in RPR/INGN 201 clinical program for treatment of advanced cancers 2AVAX Technologies' M-Vax™ cancer vaccine extends five-year overall survival in patients with lymph node metastatic melanoma 2AVAX Technologies' M-Vax™ cancer vaccine extends five-year overall survival in patients with lymph node metastatic melanoma 3Hormone replacement therapy (HRT) may protect against cognitive decline in women 65 and older who have a certain genetic make-up 2Battery-operated pen quickly disinfects drinking water 2